Abstract
The rate of diagnosis of advanced lung adenocarcinoma must be improved. In this study, we compared the detection rates of EGFR-tyrosine kinase inhibitor-sensitizing mutations (mEGFRs) in bronchial washing fluid (BWF) and the plasma of patients with lung adenocarcinoma using the tissue genotype as the standard reference. Paired blood and BWF specimens were collected from 73 patients with lung cancer. The tumor EGFR mutation status was determined by genotyping of the plasma and BWF samples using droplet digital PCR (ddPCR). The study cohort included 26, 10, 10, and 27 patients with stage I, II, III, and IV disease. Of the 73 cases, 35 had a wild-type EGFR, and 19 had the L858R substitution and exon 19 deletion mutations. The areas under the receiver operator characteristic curves for sensitivity vs. specificity of ddPCR were 0.895 [95% confidence interval (CI): 0.822-0.969] for BWF and 0.686 (95% CI: 0.592-0.780) for plasma (p < 0.001). The fractional abundance was higher in BWF of the mEGFR-positive cases than in the plasma (p = 0.004), facilitating easy threshold setting and discrimination between mEGFR-positive and negative cases. When genotyping results obtained using plasma and BWF were compared for early lung cancer (stages...Continue Reading
References
Jan 1, 1992·Respiration; International Review of Thoracic Diseases·G Semenzato, V Poletti
May 1, 2004·The New England Journal of Medicine·Thomas J LynchDaniel A Haber
Nov 1, 2005·Lancet·Nick ThatcherKevin Carroll
Nov 3, 2007·Seminars in Respiratory and Critical Care Medicine·Venerino PolettiMarco Chilosi
Aug 21, 2009·The New England Journal of Medicine·Tony S MokMasahiro Fukuoka
Feb 22, 2011·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Tonio OumeraciNils von Neuhoff
Feb 28, 2013·Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer·Alda L TamSanjay Gupta
May 10, 2013·Chest·M Patricia RiveraMomen M Wahidi
Jan 23, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Luis A Diaz, Alberto Bardelli
Oct 24, 2015·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Kenneth S ThressJ Carl Barrett
Apr 8, 2016·JAMA Oncology·Adrian G SacherGeoffrey R Oxnard
Feb 9, 2017·Scientific Reports·Ana Sofia CarvalhoRune Matthiesen
Feb 15, 2017·Clinical Chemistry and Laboratory Medicine : CCLM·Sojung ParkChang-Min Choi
Dec 8, 2017·Annals of Oncology : Official Journal of the European Society for Medical Oncology·A K KrugJ Skog
Jan 5, 2018·Translational Lung Cancer Research·José Luís González-LarribaRosario García-Campelo
Jan 10, 2018·CA: a Cancer Journal for Clinicians·Rebecca L SiegelAhmedin Jemal
Mar 12, 2018·Translational Oncology·Wei-Neng FengYan-Ming Deng
May 22, 2018·Journal of Thoracic Disease·Wenhua LiangJianxing He
Jun 19, 2018·Current Oncology·M Cabanero, M S Tsao
Jul 28, 2018·Translational Lung Cancer Research·Patricia M de GrootReginald F Munden
Nov 15, 2018·Micromachines·Minji LimYoon-Kyoung Cho
Mar 21, 2019·Frontiers in Oncology·Jatta SaarenheimoAntti Jekunen
May 28, 2019·Yonsei Medical Journal·Min Hee HongByoung Chul Cho
Citations
May 15, 2021·Frontiers in Oncology·Jinfang ZhaiWeihua Yang
Aug 28, 2021·Biomedicines·Irina Palacín-AlianaÁngel Ayuso-Sacido
Nov 14, 2021·Molecular Diagnosis & Therapy·Susana Olmedillas-LópezDamián García-Olmo